Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-20-023944

Options or other derivatives

  • Director acquired 86,735 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Booth Bruce Director 2020-04-06 Grant or award · Stock Option (Right to Buy) +86,735 $0.22 $19,125 86,735 D
Loading xslF345X03/doc4.xml…